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Abstract
Primary lung myoepithelial carcinomas are rare neoplasms arising from the salivary glands of the respiratory
epithelium. Given the rare occurrences and reports of these tumors, appropriate recommendations for resection
are difficult to formulate. Although classified as low-grade neoplasms, these tumors have a significant rate of
recurrence and distant metastasis.
Introduction
Primary salivary gland-type tumors of the lung are rare
and include mucoepidermoid carcinoma, adenoid cystic
carcinoma, acinic cell carcinoma, oncocytoma, epithe-
lial-myoepithelial carcinoma, benign myoepithelioma,
and mixed tumors of both benign and malignant nature
[1-16]. Primary pulmonary myoepithelial carcinomas are
exceedingly rare, with only five known prior cases
reported in the English literature to date [17-20]. We
report a case of primary myoepithelial carcinoma of the
lung and a review of the literature.
Case Report
A 63-year-old woman presented to the clinic with a his-
tory of increasing pulmonary congestion, difficulty
expectorating, and low-grade hemoptysis. Her past med-
ical history was significant for diet-controlled insulin-
dependent diabetes mellitus. There was no history of
cigarette or other tobacco use. Her mother had died of
breast cancer in her fifties. A chest radiograph showed a
large mass in the right lower lung fields, and computed
tomography scanning revealed a 12.4 × 8.3 centimeter
smoothly circumscribed heterogeneous mass arising in
the right minor fissure and impinging upon the right
atrium (Figure 1A). A fine needle aspiration was per-
formed which yielded a diagnosis initially suspicious for
schwannoma, as reviewed at an outside institution. At
the time of thoracotomy, dense adhesions were dissected
free of the upper and middle lobes with no evidence of
tumor invasion, and the mass was resected en-bloc with
pericardium and a wedge resection of the lower lobe.
An additional separate lower lobe nodule was also
excised and presumed to be a metastatic focus of tumor.
The patient had an uneventful recovery and was dis-
charged home on post-operative day number three.
The patient developed a biopsy proven solitary liver/
diaphragmatic metastasis diagnosed on routine follow-
up at 36 months post-resection.
Pathologic Findings
Gross pathologic examination revealed the mass to be a
13 × 8 × 8 centimeter lower lobe carcinoma of myoe-
pithelial origin involving the visceral pleura (Figure 1B).
Histologically, the mass was consistent with a malig-
nant myoepithelial neoplasm with a fibrous capsule and
20% necrosis. The mass was thought to arise from the
right lower lobe and involved the visceral pleura. The
margin was focally within 0.1 cm of the tumor, but
otherwise grossly free of invasion. The separate nodule
was 1 cm in size and histologically similar to the pri-
mary tumor.
Immunohistochemical stains were performed and were
focally positive for AE1/AE3, Bcl2, Cam5.2, S100p,
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Myoepithelial carcinomas primarily arise from the sali-
vary glands, the parotid, or the breast [21]. Rarely, they
may arise in soft tissues, most often in the lower and
upper limbs, occurring equally in men and women [22].
These soft-tissue tumors, distinguished from benign
myoepitheliomas by their moderate or severe cytologic
atypia or invasive growth pattern, recur locally in 42% of
patients and metastasize to distant sites in 32%.
Primary myoepithelial carcinomas of the lung are
exceedingly rare, with only 6 patients reported in the
English literature, including the present report [17-20].
Clinical data from these reports are summarized in
Table 1. Very limited information was available for one
patient [20]. Most patients were male, in their fifth or
sixth decade of life at diagnosis, and smoked tobacco.
Most patients presented with primarily endobronchial
disease, had preoperative biopsies of their tumors, and
Figure 1 Radiographic and gross pathologic appearance of primary pulmonary myoepithelial carcinoma. A. Computed tomography of
right-sided chest mass with compression of right atrium. B. Gross pathologic appearance of right visceral pleural mass.
Table 1 Clinical characteristics of reported cases of myoepithelial carcinoma of the lung
AUTHOR Age/
Sex
Smoking Location Pre-op Bx
Diagnosis
Size
(cm)
Resection Type Local
Recurrence
Metastasis Outcome
Present case 63F No RLL, Pleural &
parenchymal
Low grade
spindle cell
neoplasm
13.0 Wedge/Local
excision
No Yes, same lobe/
pleura at time of
resection, liver at 36
months
AWD at 36 months
Masuya 2005 48M Yes LLL,
Parenchymal
&
Endobronchial
Sarcoma,
sarcomatoid
carcinoma,
carcinosarcoma
1.5 Lobectomy No No NED 15 months
Miura 2000 46M NA Right hilum,
Right Main
Stem,
Endobronchial
No atypical
cells
6.5 Pneumonectomy No Yes, LLL AWD at 7 months
Higashiyama 58M Yes RUL,
Endobronchial
NA 3.8 Sleeve
bilobectomy
(RUL/RML)
No Yes, soft tissue left
arm and hip
DOC at 14 months
(metastatic
synchronous
adenocarcinoma)
Higashiyama
1998
58M Yes LUL,
Endobronchial
Squamous cell
carcinoma
6.0 Sleeve
lobectomy (LUL)
No Yes, liver DOD, 60 months
Sekine 1998 NA NA NA NA NA NA NA Yes NA
RLL - right lower lobe; LLL - left lower lobe; RUL - right upper lobe; LUL - left upper lobe; RML - right middle lobe; Bx - biopsy; NED - no evidence of disease;
AWD - alive with disease; DOC - dead of other causes; DOD - dead of disease.
Sarkaria et al. Journal of Cardiothoracic Surgery 2011, 6:27
http://www.cardiothoracicsurgery.org/content/6/1/27
Page 2 of 3underwent anatomic resections of these malignancies.
There were no local recurrences. Almost all patients
had metastatic disease, either synchronous at time of
resection, or presenting as metachronous recurrence.
Follow-up was less than two years for all but one
patient, who died of metastatic disease to the liver five
years postoperatively. One other patient died at fourteen
months from synchronous metastatic adenocarcinoma.
One patient was alive with disease, and two others were
free of disease at relatively short follow-up intervals.
Given the available reported data, there are a number
of unique characteristics of the current case when com-
pared to the previous five. This case represents the eld-
est and only female patient, as well as the only known
never-smoker. This patient’s tumor is also the greatest
in size within this series, more than doubling the pre-
vious known largest of these tumors. All other patients
in the series presented with a major component of
endobronchial disease, whereas the current tumor was
primarily pleural/parenchymal based. Finally, the current
case represents the only patient treated with a limited
sub-anatomic resection.
Given the relatively high rates of recurrence, low-grade
malignant status, and the propensity for recurrence at dis-
tant sites, it is reasonable to consider limited sub-anatomic,
parenchymal sparing resections for these patients, espe-
cially if pneumonectomy is contemplated. While this may
not be adequate for endobronchial lesions involving major
pulmonary segments, it is feasible for lesions presenting
with primarily parenchymal or pleural based disease, as in
the current case. Given the rarity of these tumors, recom-
mendations regarding chemotherapy or radiation, either
pre- or postoperatively, are difficult to formulate.
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